Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
05/2003
05/01/2003US20030082603 Colon cancer marker
05/01/2003US20030082599 Polynucleotide
05/01/2003US20030082591 Methods for gene disruption and uses thereof
05/01/2003US20030082575 Translation system for use in the generation of protein containing adjusted amino acid sequences
05/01/2003US20030082554 Nucleotide sequences coding polypeptide for use in the treatment of immunlological, thyroid, metabolic, bone and pancreatic disorders
05/01/2003US20030082546 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders and cancer
05/01/2003US20030082206 Method of preserving infectious recombinant viruses, aqueous viral suspension, and use as medicament
05/01/2003US20030082202 Tryparedoxin, expression plasmid, process of production, method of use, test kit, and pharmaceutical composition
05/01/2003US20030082201 Genetic engineering; polymerase chain reaction
05/01/2003US20030082200 Protein binding to immobilized vitronectin
05/01/2003US20030082198 Administering complex of heat shock protein and antigen
05/01/2003US20030082197 Administering complex of heat shock protein and antigen
05/01/2003US20030082190 Fusion molecules and treatment of IgE-mediated allergic diseases
05/01/2003US20030082173 Screening drugs that block lymphocytes; genetic engineered rodent
05/01/2003US20030082172 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
05/01/2003US20030082166 Compounds and methods for modulating nonclassical cadherin-mediated functions
05/01/2003US20030082165 Novel biofungicide
05/01/2003US20030082164 Controlling plant fungi
05/01/2003US20030082147 Harvesting bacteria fron nematode culture; reproduction; inoculation
05/01/2003CA2842429A1 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
05/01/2003CA2793019A1 Humanized antibodies
05/01/2003CA2675409A1 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
05/01/2003CA2470197A1 Mycobacterial genes down-regulated during latency
05/01/2003CA2468125A1 Target specific screening and its use for identifying target binders
05/01/2003CA2464372A1 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof
05/01/2003CA2464349A1 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof
05/01/2003CA2464239A1 Psma antibodies and protein multimers
05/01/2003CA2463772A1 Thrombin-cleavable chimeric proteins
05/01/2003CA2461665A1 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
05/01/2003CA2461543A1 Sperm factor sequences
05/01/2003CA2460665A1 Peptides and proteins binding to glu-pro motifs, therapeutical compositions containing them and their applications
05/01/2003CA2458794A1 Plasticized hydrophilic glasses for improved stabilization of biological agents
05/01/2003CA2454361A1 Humanized antibodies
04/2003
04/30/2003CN1415019A Method for making insulin precursors and insulin precursor analogus having improved fermentation yield in yeast
04/30/2003CN1415018A Microbiological method for producing aromatic aldehydes and/of carboxylic acids
04/30/2003CN1415016A Trichoderma reesei木聚糖酶 Trichoderma reesei xylanase
04/30/2003CN1415015A Process for biological preparation of L-pipecolic acid
04/30/2003CN1415014A Increased lysine production by gene amplification
04/30/2003CN1415013A BASB059 polypeptides from neisseria meningitidis
04/30/2003CN1415012A Human proteins binding to human tyrosine kinase HcK and genes encoding the same
04/30/2003CN1414974A Method for making insulin precursors and insulin precursor analogs
04/30/2003CN1414973A Insecticidal proteins from bacillus thuringiensis
04/30/2003CN1414105A Method of constructing genetic engineering organism based on in vivo isogenesis recombination
04/30/2003CN1414094A Using yeast secretion to express ruitipu enzyme
04/30/2003CN1414093A Microbial fertilizer bacterial agent for direct decomposing straw as fertilizer and its production process and application method
04/30/2003CN1414092A Additive for photosyntheric bacterial culture medium
04/30/2003CN1414091A New technology of culturing cordyceps sinensis using insect
04/30/2003CN1107115C System for expression of heterologous antigens as fusion proteins
04/30/2003CN1107112C Wine with shaped Chinese caterpillar fungus soaked in and its production method
04/30/2003CN1107072C Programing cell death induced molecule II
04/30/2003CN1106870C Biodegradation of metal cyanides
04/30/2003CA2409536A1 Self-sustaining fermentation medium preparation process
04/29/2003US6555733 Genes coding for amino acid deacetylases with specificity for N-acetyl-L-phosphinothricin, their isolation and use
04/29/2003US6555669 Nucleotide sequences coding preferential oligopeptide for use in human therapeutics and diagnostics; for use in the treatment of cancer and Parkinson's Disease
04/29/2003US6555666 Transcripts encoding immunomodulatory polypeptides
04/29/2003US6555657 Isolated transcription factor for an alpha-amylase promoter in filamentous fungi
04/29/2003US6555655 Novel insecticidal polypeptides of given amino acid sequence obtained by culturing Bacillus thuringiensis NRRL B-21915 or NRRL B-21916 cells
04/29/2003US6555653 Compounds for diagnosis of tuberculosis and methods for their use
04/29/2003US6555566 Methods and materials for treating and preventing inflammation of mucosal tissue
04/29/2003US6555520 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and immunologicval disorders
04/29/2003US6555371 Enzyme which synthesizes ganglioside by transferring sialic acid to a galactose residue of lactosylceramide
04/29/2003US6555366 Coding for a specific protein of interest in bacillus strains
04/29/2003US6555358 Chemotherapeutic target for antiprotozoal agents
04/29/2003US6555357 Structure-specific nucleases derived from thermostable organisms, used to cleave target-dependent cleavage structures
04/29/2003US6555356 Methods for microbial regulation
04/29/2003US6555355 Mutating the genes for a number of subtilases and expressing the in suitable hosts
04/29/2003US6555353 Methanotrophic carbon metabolism pathway genes and enzymes
04/29/2003US6555352 Peptide for use in human therapeutics and diagnostic compositions
04/29/2003US6555348 Enzyme isolated from a Bifidobacterium
04/29/2003US6555345 Papilloma viruses, agents for detecting them and for treating diseases caused by such viruses
04/29/2003US6555339 Altering human G protein-coupled receptors (GPCRs) by point mutation; use in drug screening
04/29/2003US6555338 Given nucleotide sequence; use of polynucleotides and polypeptides in diagnostic assays, and possibly functional genomics
04/29/2003US6555335 Xylanase from Trichoderma reesei , method for production thereof, and methods employing this enzyme
04/29/2003US6555325 Kit for screening of test compounds that modulate a heterologous G protein-coupled receptor in a yeast cell uses a mixture of yeast cells; modulators of heterologous receptors coupled to the pheromone response pathway in yeast
04/29/2003US6555319 Antibodies for inhibiting blood coagulation and methods of use thereof
04/29/2003US6555315 Capturing genes potentially encoding novel biochemical pathways of interest in prokaryotic systems, and screening for these pathways using high throughput screening assays
04/29/2003CA2281206C Geranyl diphosphate synthase genes
04/29/2003CA2159098C Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof
04/29/2003CA2152898C Recombinant lactic acid bacterium containing an inserted promoter and method of constructing same
04/29/2003CA1341428C Synthetic insecticidal crystal protein gene
04/24/2003WO2003034275A2 Chimeric glycosylphosphatidylinositol containing peptides
04/24/2003WO2003034149A1 Process and materials for formation of patterned films of functional materials
04/24/2003WO2003033740A2 Apparatus and method for isolating a nucleic acid
04/24/2003WO2003033720A2 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders
04/24/2003WO2003033710A1 Novel n-acetylglucosamine transferase, nucleic acid encoding the same, antibody against the same and use thereof for diagnosing cancer or tumor
04/24/2003WO2003033707A1 Enzyme gene participating in the synthesis of polyester and process for producing polyester using the same
04/24/2003WO2003033705A1 Transgenic organism expressing fungal mrp-like abc transporters
04/24/2003WO2003033704A1 Gene of enzyme reactivating dna damaged by ultraviolet light using visible light
04/24/2003WO2003033703A2 Human gtp-activator protein for rab-like gtpase
04/24/2003WO2003033699A2 Production, detection and use of transformant cells
04/24/2003WO2003033698A1 Method for unspecific enrichment of bacteria cells
04/24/2003WO2003033693A1 Fluorescent protein
04/24/2003WO2003033681A2 Composition comprising a lactobacillus pentosus strain and uses thereof
04/24/2003WO2003033680A2 Kinases and phosphatases
04/24/2003WO2003033677A2 Dimerized growth factor and materials and methods for producing it
04/24/2003WO2003033674A2 Human antibodies that have mn binding and cell adhesion-neutralizing activity
04/24/2003WO2003033664A2 Bone anti-resorptive compounds
04/24/2003WO2003033654A2 Direct targeting binding proteins
04/24/2003WO2003033653A2 Affinity enhancement agents
04/24/2003WO2003033538A1 Anti-hla-dr antibody
1 ... 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 ... 1489